Literature DB >> 7333672

Inhibition of formylmethionyl-leucyl-phenylalanine-stimulated neutrophil chemiluminescence by human immunoglobulin A paraproteins.

D E Van Epps, S L Brown.   

Abstract

Immunoglobulin A (IgA) paraproteins from patients with myeloma have been shown to inhibit human neutrophil chemotaxis to C5a, casein, and chemotactic factors produced by Escherichia coli. This study demonstrates that these paraproteins also inhibit neutrophil chemotaxis in response to the synthetic peptide formylmethionyl-leucyl-phenylalanine (f-MLP). Furthermore, the neutrophil chemiluminescence response stimulated by f-MLP was markedly suppressed by the presence of IgA paraprotein. Maximal inhibition of chemiluminescence was observed when the paraprotein was present during the chemiluminescence response. The inhibitory activity was substantially reduced by removal of the Fc region of IgA or by conversion of polymeric IgA to monomeric IgA by limited reduction and alkylation. Additional experiments showed that these IgA paraproteins inhibited C5a but not phorbol myristate acetate-stimulated chemiluminescence. These observations are constant with the hypothesis that polymeric forms of IgA bind to human neutrophils and interfere with the binding of chemotactic factor to its receptor or the consequent receptor-mediated oxidative burst or both.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7333672      PMCID: PMC350949          DOI: 10.1128/iai.34.3.864-870.1981

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  14 in total

1.  Suppressive effect of IgA soluble immune complexes on neutrophil chemotaxis.

Authors:  S Ito; H Mikawa; K Shinomiya; T Yoshida
Journal:  Clin Exp Immunol       Date:  1979-09       Impact factor: 4.330

2.  Defective initiation of oxidative metabolism in polymorphonuclear leukocytes.

Authors:  L Harvath; B R Andersen
Journal:  N Engl J Med       Date:  1979-05-17       Impact factor: 91.245

3.  Suppression of human PMN bactericidal activity by human IgA paraproteins.

Authors:  D E Van Epps; K Reed; R C Williams
Journal:  Cell Immunol       Date:  1978-03-15       Impact factor: 4.868

4.  Leucocyte function in paraproteinaemia.

Authors:  J B Ziegler; P J Hansen; R Penny
Journal:  Aust N Z J Med       Date:  1975-02

5.  Cytophilic properties of IgA to human neutrophils.

Authors:  H L Spiegelberg; D A Lawrence; P Henson
Journal:  Adv Exp Med Biol       Date:  1974       Impact factor: 2.622

6.  Mechanism of immunoglobulin A polymerization.

Authors:  S P Hauptman; T B Tomasi
Journal:  J Biol Chem       Date:  1975-05-25       Impact factor: 5.157

7.  The nature of the polymeric serum IgA in man.

Authors:  J Radl; A C Swart; J Mestecky
Journal:  Proc Soc Exp Biol Med       Date:  1975-11

8.  Antibodies to human albumin in cirrhotic sera.

Authors:  S Hauptman; T B Tomasi
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

9.  Suppression of leukocyte chemotaxis by human IgA myeloma components.

Authors:  D E Van Epps; R C Williams
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides.

Authors:  G E Hatch; D E Gardner; D B Menzel
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

View more
  14 in total

Review 1.  Receptors for IgA on phagocytic cells.

Authors:  L Shen
Journal:  Immunol Res       Date:  1992       Impact factor: 2.829

Review 2.  The structure and function of human IgA.

Authors:  M A Kerr
Journal:  Biochem J       Date:  1990-10-15       Impact factor: 3.857

3.  IgA-mediated inhibition of human leucocyte function by interference with Fc gamma and C3b receptors.

Authors:  K Saito; C Kato; H Katsuragi; A Komatsuzaki
Journal:  Immunology       Date:  1991-09       Impact factor: 7.397

4.  An enzyme-assessed microplate-assay for neutrophil adherence. I. IgA-induced adherence of human PMNs.

Authors:  W W Bullock; M Rogers; W L Gabler; H R Creamer
Journal:  Inflammation       Date:  1990-08       Impact factor: 4.092

Review 5.  Immunoglobulin A: A next generation of therapeutic antibodies?

Authors:  Jantine E Bakema; Marjolein van Egmond
Journal:  MAbs       Date:  2011-07-01       Impact factor: 5.857

6.  Intravenous immune globulin impairs anti-bacterial defences of a cyclophosphamide-treated host.

Authors:  A S Cross; G Siegel; W R Byrne; M Trautmann; D S Finbloom
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

7.  Pattern of formylmethionyl-leucyl-phenylalanine-induced luminol- and lucigenin-dependent chemiluminescence in human neutrophils.

Authors:  C Dahlgren; H Aniansson; K E Magnusson
Journal:  Infect Immun       Date:  1985-01       Impact factor: 3.441

8.  IgG and IgA enhance the chrysotile-induced production of reactive oxygen metabolites by human polymorphonuclear leucocytes.

Authors:  M Klockars; M Hedenborg; J Koistinen; T Isobe
Journal:  Clin Exp Immunol       Date:  1989-12       Impact factor: 4.330

9.  Influenza A virus-induced polymorphonuclear leukocyte dysfunction.

Authors:  J S Abramson; D S Lyles; K A Heller; D A Bass
Journal:  Infect Immun       Date:  1982-08       Impact factor: 3.441

10.  Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leucocytes.

Authors:  G R Yeaman; M A Kerr
Journal:  Clin Exp Immunol       Date:  1987-04       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.